Full-Time
Bioinformatics Analyst
Posted on 8/6/2022
AI-driven precision medicine through clinical and molecular data analysis
Junior, Mid, Senior
Chicago, IL, USA
- BS/BA in bioinformatics, computer science, molecular biology or genetics, or equivalent field of study
- Programming skills: SQL, Bash, Python or R
- Computational biology skills using Python, R, and/or Bioconductor
- Experience working with next-generation sequencing data
- Familiarity with Mac/Linux working environment
- Must be flexible to work on the weekends
- Advanced degree in Bioinformatics, computational biology, genomics, or equivalent field of study
- Work experience in cancer genetics or molecular biology
- Familiarity with next-gen sequencing lab practices
- Previous experience working with next-gen sequencing data
- Capacity to excel in an interdisciplinary team environment
- Software development experience using Github
- Experience with communicating insights and presenting concepts to a diverse audience
- Familiarity with cloud computing environments
- Provide bioinformatics support for quality control and variant identification/interpretation, prior to clinical case sign outs
- Evaluate sample and variant metrics to confirm data quality and integrity
- Provide timely notifications to laboratory and clinical personnel regarding potential sample irregularities
- Interpretation of single-nucleotide, insertion/deletion, and copy number variants and fusions
- Responsible for identifying and interpreting complex variant calls in low coverage, variable, and novel genomic regions, in addition to sequencing artifacts
- Use SQL and other scripting languages to retrieve relevant data from various bioinformatics databases
- Use Python and/or R to perform analyses on genomic data sets
- Communicate findings in a clear and logical manner to help stakeholders make scientific and clinical decisions based on your interpretation of variant data
- Produce high quality and detailed documentation for all analysis/projects
Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.
Company Stage
Series G
Total Funding
$1.3B
Headquarters
Chicago, Illinois
Founded
2015